A. Howard

发表

Piperacillin/tazobactam-resistant, cephalosporin-susceptible Escherichia coli bloodstream infections are driven by multiple acquisition of resistance across diverse sequence types

L. Cuevas, A. Roberts, C. Parry, 2022, Microbial genomics.

Piperacillin/tazobactam resistant, cephalosporin susceptible Escherichia coli bloodstream infections are driven by multiple acquisition of resistance across diverse sequence types

L. Cuevas, A. Roberts, C. Parry, 2020, bioRxiv.

Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of blaTEM-1B

A. Roberts, C. Parry, P. Roberts, 2020, Nature Communications.

CON: Serum biomarker monitoring should not replace primary antifungal chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer therapy

W. Hope, A. Howard, 2022, JAC-antimicrobial resistance.

Within-patient evolution to piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of blaTEM-1B

A. Roberts, C. Parry, P. Roberts, 2020, bioRxiv.

Essential for Viability

A. Howard, A. Sadosky, '. Wilson, 2022 .

Impact of different carbapenemase-producing Enterobacterales screening strategies in a hospital setting☆

A. Howard, C. Corless, T. Neal, 2020, Infection prevention in practice.

Escherichia coli serotypes throughout the gastrointestinal tract of patients with intestinal disorders.

S. Gorbach, A. Howard, S. Tabaqchali, 1977, Gut.

An outbreak of Shiga toxin-producing Escherichia coli serogroup O157 linked to a lamb-feeding event

T. Dallman, C. Jenkins, A. Howard, 2016, Epidemiology and Infection.

Assessment of Antifungal Pharmacodynamics

W. Hope, A. Howard, 2023, Journal of fungi.